EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tubular cell senescence promotes maladaptive kidney repair and chronic kidney disease after cisplatin nephrotoxicity

Siyao Li, Man J Livingston, Zhengwei Ma, Xiaoru Hu, Lu Wen, Han-Fei Ding, Daohong Zhou, Zheng Dong

JCI Insight · 24.04.2023 · 8 (8)

DOI: 10.1172/jci.insight.166643 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCI Insight, online erschienen am 24.04.2023. Verfasst von Siyao Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The Second Xiangya Hospital of Central South University, Hunan Key Laboratory of Kidney Disease and Blood Purification, Cha…. Hauptthemen laut MEDLINE: Cisplatin, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 131-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NIDDK NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cisplatin is a widely used chemotherapy drug; however, it induces both acute and chronic kidney diseases (CKD) in patients with cancer. The pathogenesis of cisplatin-induced CKD is unclear, and effective renoprotective approaches are not available. Here, we report that repeated low-dose cisplatin (RLDC) treatment of C57BL/6 mice induced chronic cellular senescence in kidney tubules, accompanied with tubular degeneration and profibrotic phenotype transformation that culminated in maladaptive repair and renal fibrosis. Suppression of tubular senescence by senolytic drugs ABT-263 and Fisetin attenuated renal fibrosis and improved tubular repair, as indicated by restoration of tubular regeneration and renal function. In vitro, RLDC also induced senescence in mouse proximal tubular (BUMPT) cells. ABT-263 eliminated senescent BUMPT cells following RLDC treatment, reversed the profibrotic phenotype of the cells, and increased their clonogenic activity. Moreover, ABT-263 alleviated the paracrine effect of RLDC-treated BUMPT cells on fibroblasts for fibrosis. Consistently, knockdown of p16 suppressed post-RLDC senescence and fibrotic changes in BUMPT cells and alleviated their paracrine effects on renal fibroblast proliferation. These results indicate that persistent induction of tubular senescence plays an important role in promoting cisplatin-induced CKD. Targeting senescent tubular cells may be efficient for improvement of kidney repair and for the prevention and treatment of cisplatin-induced CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinRenal Insufficiency, ChronicMiceAnimalsMice, Inbred C57BLKidneyCellular SenescenceFibrosisAniline CompoundsSulfonamides

Stichwörter der Autor:innen

Cellular senescenceChronic kidney diseaseNephrology

Substanzen

CisplatinnavitoclaxAniline CompoundsSulfonamides

Autor:innen und Institutionen

  • Department of Nephrology, The Second Xiangya Hospital of Central South University, Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, China.
  • Department of Cellular Biology and Anatomy, Medical College of Georgia at Augusta University, Augusta, Georgia, USA.
  • Division of Molecular and Cellular Pathology, Department of Pathology, University of Alabama School of Medicine at Birmingham, Birmingham, Alabama, USA.
  • Center for Innovative Drug Development and Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
  • Research Department, Charlie Norwood VA Medical Center, Augusta, Georgia, USA.

Förderung

  • BLRD VA
  • NIDDK NIH HHS
  • National Institutes of Health
  • U.S. Department of Veterans Affairs

Zitieren

APA

Li, S., Livingston, M. J., Ma, Z., Hu, X., Wen, L., Ding, H. F., Zhou, D., & Dong, Z. (2023). Tubular cell senescence promotes maladaptive kidney repair and chronic kidney disease after cisplatin nephrotoxicity. JCI Insight, 8(8). https://doi.org/10.1172/jci.insight.166643

Vancouver

Li S, Livingston MJ, Ma Z, Hu X, Wen L, Ding HF, et al. Tubular cell senescence promotes maladaptive kidney repair and chronic kidney disease after cisplatin nephrotoxicity. JCI Insight. 2023;8(8). doi:10.1172/jci.insight.166643

BibTeX
@article{Li2023,
  author = {Li, Siyao and Livingston, Man J and Ma, Zhengwei and Hu, Xiaoru and Wen, Lu and Ding, Han-Fei and Zhou, Daohong and Dong, Zheng},
  title = {Tubular cell senescence promotes maladaptive kidney repair and chronic kidney disease after cisplatin nephrotoxicity},
  journal = {JCI Insight},
  year = {2023},
  volume = {8},
  number = {8},
  doi = {10.1172/jci.insight.166643}
}
Kostenlos starten →